418
Participants
Start Date
December 11, 2012
Primary Completion Date
March 12, 2015
Study Completion Date
October 31, 2015
OCT stent guidance
Participants undergoing pre- and post-PCI fractional flow reserve (FFR) and OCT
University Hospital - Univ. of Alabama at Birmingham (UAB), Birmingham
Loyola University Chicago, Maywood
Scripps Clinic, Green Hospital, La Jolla
Florida Hospital Orlando, Orlando
Emory University Hospital, Atlanta
Central Baptist Hospital, Lexington
Baptist Health East, Louisville
St. Luke's Hospital/Mid America Heart, Kansas City
Rutgers Cardiovascular Institute, New Brunswick
Mount Sinai Medical Center, New York
Heart Hospital of Austin, Austin
Dallas VA Medical Center, Dallas
University of Texas Medical Branch at Galveston, Galveston
Swedish Medical Center, Seattle
Aurora St. Luke's Medical Center, Milwaukee
The Prince Charles Hospital, Chermside
Med. Univ. Vienna, Vienna
OLV Hospital, Aalst
Gasthuisberg Leuven, Leuven
Montreal Heart Institute, Montreal
University of Hong Kong, Hong Kong
University Hospital Brno, Brno
CHU Clermont Ferrand, Clermont-Ferrand
CHC du Marie Lannelongue, Le Plessis-Robinson
Clinique Pasteur, Toulouse
Deutsches Herzzentrum, Munich
Ospedali Riuniti di Bergamo, Bergamo
Centro Cardiologico Monzino, Milan
Ospedale San Giovanni Addolorata, Rome
Kobe University Graduate School of Medicine, Hyōgo
Nara Medical University Hospital, Nara
Osaka Saiseikai Nakatsu Hospital, Osaka
Wakayama Medical University, Wakayama
Thoraxcentre Erasmus MC, Rotterdam
Hospital Univ. Clinico San Carlos, Madrid
Royal Brompton Hospital, London
Lead Sponsor
Abbott Medical Devices
INDUSTRY